SEC Company Response from Paratek Pharmaceuticals, Inc. (CIK 0001178711) — Jul 7, 2020
Paratek Pharmaceuticals, Inc. (CIK 0001178711)
Date: July 7, 2020 · CIK: 0001178711 · Accession: 0001564590-20-031907
AI Filing Summary & Sentiment
File numbers found in text: 333-238150
Letter
prtk-corresp.DOCX.htm
PARATEK PHARMACEUTICALS, INC.
75 Park Plaza
Boston, Massachusetts 02116
(617) 807-6600
July 7, 2020
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F. Street, N.E.
Washington, D.C. 20549
RE: Paratek Pharmaceuticals, Inc.
Registration Statement on Form S-3, as amended (File No. 333-238150)
Request for Acceleration
Ladies and Gentlemen:
Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Paratek Pharmaceuticals, Inc., a Delaware corporation (the “Company”), hereby respectfully requests that the effective date of its Registration Statement on Form S-3, as amended (File No. 333-238150) (the “Registration Statement”) be accelerated by the Securities and Exchange Commission so that it will be declared effective at 4:00 p.m. Eastern Time on July 9, 2020, or as soon as possible thereafter. The Company hereby authorizes Thomas J. Danielski of Ropes & Gray LLP, counsel to the Company, to orally modify or withdraw this request for acceleration.
It would be appreciated if, as soon as the Registration Statement is declared effective, you would inform Thomas J. Danielski of Ropes & Gray LLP at thomas.danielski@ropesgray.com or (617) 235-4961.
Very truly yours,
PARATEK PHARMACEUTICALS, INC.
Show Raw Text
CORRESP
1
filename1.htm
prtk-corresp.DOCX.htm
PARATEK PHARMACEUTICALS, INC.
75 Park Plaza
Boston, Massachusetts 02116
(617) 807-6600
July 7, 2020
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F. Street, N.E.
Washington, D.C. 20549
RE: Paratek Pharmaceuticals, Inc.
Registration Statement on Form S-3, as amended (File No. 333-238150)
Request for Acceleration
Ladies and Gentlemen:
Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Paratek Pharmaceuticals, Inc., a Delaware corporation (the “Company”), hereby respectfully requests that the effective date of its Registration Statement on Form S-3, as amended (File No. 333-238150) (the “Registration Statement”) be accelerated by the Securities and Exchange Commission so that it will be declared effective at 4:00 p.m. Eastern Time on July 9, 2020, or as soon as possible thereafter. The Company hereby authorizes Thomas J. Danielski of Ropes & Gray LLP, counsel to the Company, to orally modify or withdraw this request for acceleration.
It would be appreciated if, as soon as the Registration Statement is declared effective, you would inform Thomas J. Danielski of Ropes & Gray LLP at thomas.danielski@ropesgray.com or (617) 235-4961.
Very truly yours,
PARATEK PHARMACEUTICALS, INC.
By:
/s/ William M. Haskel
William M. Haskel
Senior Vice President, General Counsel and Corporate Secretary